- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04410692
Can the Prediction Market Improve Predictions of COVID-19?
The goal of this study is to better understand how people predict the future risks of the novel Coronavirus (COVID-19).
Specifically, the investigators will ask the following research questions:
- How well do participants predict the future risks of COVID-19?
- Can the predictions be improved by using a prediction market mechanism?
- Does the prediction market reduce people's fear of COVID-19?
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
The proposed study is an online experiment. Students enrolled at National University of Singapore are recruited to participate in the study.
Participants will first complete a pre-experiment survey, which contains basic demographic questions. Then, participants will be randomly assigned to one of two conditions: "Survey" and "Prediction Market".
"SURVEY" CONDITION:
Participants in the "Survey" condition are asked 16 prediction questions in a survey format. The questions are of the following format:
"What do you think will be the total cumulative number of cases in Singapore on 8th of June, at 12pm?"
Each question has 5 answer options. Each answer option is a range of outcomes, e.g. "< 28,900", "between 28,900 and 33,899", "between 33,900 and 38,899", "between 38,900 and 43,899", and "> 43,899". Participants are required to enter their perceived likelihood of each answer option in %.
The 16 prediction questions come from the following variations: 4 countries (Mexico, Singapore, Turkey, USA) x 2 outcome measures (cases, deaths) x 2 time periods (8th of June, 6th of July).
Participants have 24 hours to submit their predictions.
After the 24-hour period, participants are requested to fill out a post-experiment survey, which includes questions about their subjective attitudes and fears towards COVID-19.
"PREDICTION MARKET" CONDITION:
For participants in the "Prediction Market" condition, the same 16 prediction questions are presented in the form of prediction markets. The prediction market is a well-established method of eliciting people's predictions. The method is briefly described below.
There are 16 prediction markets, one for each question. Participants are given 100 tokens per market, which can be used to buy "stocks" on possible outcomes. There are 5 possible outcomes per market (identical to the 5 answer options per question in the "Survey" condition).
Each stock (i.e., possible outcome) will have a price that is dynamically determined by the central marketplace, which is a function of real-time demand and supply of the option. If the option is popular, its price will become higher, and vice versa.
Participants can trade at any time, and as many times as they want, during a 24-hour period. Upon closure of the prediction market, participants will be rewarded proportional to the number of shares that they hold on options that later turn out to be true.
The final prices of stocks correspond to the group's predictions of COVID-19.
After the 24-hour period, participants are requested to fill out a post-experiment survey, which includes questions about their subjective attitudes and fears towards COVID-19.
=====
HYPOTHESES
The prediction market leads to better predictions about COVID-19. The investigators will compare the survey predictions and the prediction-market predictions with the actual realized outcome. The investigators hypothesize that the prediction-market predictions are more accurate than the survey predictions through information aggregation.
The prediction market reduces fear. Fear is measured by participants' responses to subjective attitude questions in the post-experiment survey.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Singapore, Cingapura
- National University of Singapore
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- National University of Singapore students
Exclusion Criteria:
- N/A
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Control
Participants' COVID-19 predictions are elicited via a survey
|
|
|
Experimental: Treatment
Participants' COVID-19 predictions are elicited via a prediction market
|
Participants "bet" on likely future outcomes using a prediction market
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Predictions of COVID-19 Cases and Deaths
Prazo: 24 hours
|
Participants are asked 16 questions of the following format: "What do you think will be the total cumulative number of cases in Singapore on 8th of June, at 12pm?" Each question has 5 answer options. Each answer option is a range of possible outcomes. The primary outcome measure is participants' perceived likelihood of each answer option. The 16 questions come from the following variations: 4 countries (Mexico, Singapore, Turkey, USA) x 2 outcome measures (cases, deaths) x 2 time periods (8th of June, 6th of July). |
24 hours
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Fear
Prazo: 24 hours (participants are required to submit post-experiment survey within 24 hours of completion of the main experiment)
|
Fear is measured by participants' responses to subjective attitude questions in the post-experiment survey.
The questions are on a 5-point Likert scale.
|
24 hours (participants are required to submit post-experiment survey within 24 hours of completion of the main experiment)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Teck Ho, PhD, National University of Singapore
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- SG-COVID
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- CIF
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .